The Society of Hematologic Oncology invites industry supporters to participate during the 2018 annual meeting. The program affords our industry partners the opportunity to interact with more than 1,200 of the world’s leaders in the hematology/oncology field.
For more information regarding exhibit and support opportunities, just click the following link to download the Industry Prospectus and individual Applications.
You may also contact Belinda Melder, the industry coordinator for the conference at 1.281.364.7387 x201 or via email at firstname.lastname@example.org. If you have already reserved an exhibit space or would like more information about exhibit services or products, you may connect directly to Freeman Online to help you prepare for a successful face-to-face event.
The conference organizing committee wishes to express appreciation to the following companies for their commitment to continuing medical education by providing educational grants or donations in support of this symposium:
Gilead Sciences, Inc. • Janssen Biotech, Inc.
Seattle Genetics, Inc.
The conference committee wishes to express appreciation to the following companies:
Gilead Sciences, Inc • Janssen Biotech, Inc. • Pharmacyclics LLC • Celgene Corporation • MediCom Worldwide, Inc.
Novartis Oncology • Amgen • Pfizer • Merck & Co., Inc • AbbVie • Agios Pharmaceuticals • Jazz Pharmaceuticals, Inc. • Juno Therapeutics, Inc • Kite, a Gilead Company • Adaptive Biotechnologies • Astellas Pharma US, Inc. • Bayer • Bristol-Myers Squibb • BMS/Pfizer • Daiichi Sankyo, Inc. • Seattle Genetics, Inc • Shire • SkylineDx • Sunesis Pharmaceuticals, Inc. • Teva Oncology • Genentech
Astex Pharmaceuticals • Elsevier • MD Anderson Cancer Center